FDA Updates » Recent Cancer-Related Approvals & Updates

Here are some of the recent approvals and FDA updates for cancer survivors from the United States Food and Drug Administration.

A Decade of FDA-Approved Drugs (2010–2019): Trends and Future

FDA approves new treatment for advanced ovarian cancer - Cancer

FDA Accelerated Approval for ELREXFIO™ (elranatamab-bcmm)

2sable/dictionary.py at master · Adriandmen/2sable · GitHub

2023 forecast: FDA revamps cancer drug approvals

FDA Approval Insights: Glofitamab in Relapsed/Refractory Diffuse

RxTROSPECT — Truqap (capivasertib) plus Faslodex approved in the

FDA declines to approve ImmunityBio's bladder cancer therapy

Breakthroughs in Targeted Therapy, Immunotherapy Reduce Cancer

Please note, these are the actual video-recorded proceedings from

New Drug Application for Adagrasib Accepted by FDA for KRAS G12C+

Delivery strategies of cancer immunotherapy: recent advances and

FDA Updates » Recent Cancer-Related Approvals & Updates